EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathogenic Intronic Splice-Affecting Variants in MYBPC3 in Three Patients with Hypertrophic Cardiomyopathy

Katherine A. Wood, Jamie M. Ellingford, James Eden, Huw B. Thomas, Raymond T. O’Keefe, Claire Hopton, William G. Newman

Cardiogenetics · 02.06.2021 · 11 (2) · 73-83

DOI: 10.3390/cardiogenetics11020009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiogenetics, online erschienen am 02.06.2021. Verfasst von Katherine A. Wood und 6 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Manchester NIHR BR, BBSRC.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic variants in MYBPC3 are one of the most common causes of hypertrophic cardiomyopathy (HCM). While variants in MYBPC3 affecting canonical splice site dinucleotides are a well-characterised cause of HCM, only recently has work begun to investigate the pathogenicity of more deeply intronic variants. Here, we present three patients with HCM and intronic splice-affecting MYBPC3 variants and analyse the impact of variants on splicing using in vitro minigene assays. We show that the three variants, a novel c.927-8G>A variant and the previously reported c.1624+4A>T and c.3815-10T>G variants, result in MYBPC3 splicing errors. Analysis of blood-derived patient RNA for the c.3815-10T>G variant revealed only wild type spliced product, indicating that mis-spliced transcripts from the mutant allele are degraded. These data indicate that the c.927-8G>A variant of uncertain significance and likely benign c.3815-10T>G should be reclassified as likely pathogenic. Furthermore, we find shortcomings in commonly applied bioinformatics strategies to prioritise variants impacting MYBPC3 splicing and re-emphasise the need for functional assessment of variants of uncertain significance in diagnostic testing.

Förderung

  • Medical Research Council
  • Manchester NIHR BR
  • BBSRC

Zitieren

APA

Wood, K. A., Ellingford, J. M., Eden, J., Thomas, H. B., O’Keefe, R. T., Hopton, C., & Newman, W. G. (2021). Pathogenic Intronic Splice-Affecting Variants in MYBPC3 in Three Patients with Hypertrophic Cardiomyopathy. Cardiogenetics, 11(2), 73-83. https://doi.org/10.3390/cardiogenetics11020009

Vancouver

Wood KA, Ellingford JM, Eden J, Thomas HB, O’Keefe RT, Hopton C, et al. Pathogenic Intronic Splice-Affecting Variants in MYBPC3 in Three Patients with Hypertrophic Cardiomyopathy. Cardiogenetics. 2021;11(2):73-83. doi:10.3390/cardiogenetics11020009

BibTeX
@article{Wood2021,
  author = {Wood, Katherine A. and Ellingford, Jamie M. and Eden, James and Thomas, Huw B. and O’Keefe, Raymond T. and Hopton, Claire and Newman, William G.},
  title = {Pathogenic Intronic Splice-Affecting Variants in MYBPC3 in Three Patients with Hypertrophic Cardiomyopathy},
  journal = {Cardiogenetics},
  year = {2021},
  volume = {11},
  number = {2},
  pages = {73--83},
  doi = {10.3390/cardiogenetics11020009}
}
Kostenlos starten →